Search - tctmd.com

Displaying 721 - 740 of 790

Sort: Relevancy | Date

Presentation TVT 2014

Lotus - Status of the US Clinical Trial and Case Examples

Presenter: Ted E. Feldman, Michael J. Reardon

June 06, 2014

Presentation TVT 2014

Portico (TF and TA) Clinical Results and Status of the US Clinical Trial

Presenter: Raj Makkar

June 05, 2014

Presentation TVT 2014

Direct Flow Medical Technology Review, Clinical Results (DISCOVER), and Status of the US Clinical Trial

Presenter: Charles J. Davidson

June 05, 2014

Presentation TVT 2014

The High-Risk Randomized Trial

Presenter: Michael J. Reardon

June 05, 2014

Presentation TVT 2014

The Extreme-Risk Registry

Presenter: Jeffrey J. Popma

June 05, 2014

News Daily News

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

L.A. McKeown

June 03, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

Study Questions Ability of TAVR to Improve Psychological, General Health

L.A. McKeown

March 13, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Daily News

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

Jason Kahn

January 01, 2014

News Daily News

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Jason Kahn

January 01, 2014

News Conference News AHA 2013

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Jason Kahn

November 16, 2013

Presentation TCT 2013

TAVR Accessory Devices: How Much Clinical Trial Rigor and What Are Appropriate Surrogate Endpoints?

Presenter: Alexandra Lansky

October 30, 2013

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

Technology Review and Clinical Results (DISCOVER Trial)

Presenter: Charles Davidson

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results (REPRISE I and II Trials)

Presenter: Ian Meredith

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

Advertisement

Lotus - Status of the US Clinical Trial and Case Examples

Portico (TF and TA) Clinical Results and Status of the US Clinical Trial

Direct Flow Medical Technology Review, Clinical Results (DISCOVER), and Status of the US Clinical Trial

The High-Risk Randomized Trial

The Extreme-Risk Registry

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

Study Questions Ability of TAVR to Improve Psychological, General Health

Medtronic CoreValve® System Obtains Early FDA Approval

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Los Resultados Iniciales TAVR son Equiparables a los Resultados PARTNER, aunque con Menos Complicaciones

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

TAVR Accessory Devices: How Much Clinical Trial Rigor and What Are Appropriate Surrogate Endpoints?

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Technology Review and Clinical Results (DISCOVER Trial)

Technology Review and Clinical Results (REPRISE I and II Trials)

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content